Study cannabis effects on brain function in adults with HIV
Part of Mental health clinical trials.
This early-phase study looks at how cannabis (and the body’s cannabinoid system) may affect thinking and brain-related measures in people with HIV. You may be asked to avoid cannabis and complete several brain and health assessments to see how these factors relate.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 18 and 65 years old
- Be able to understand and sign consent for all study testing
- Confirm your HIV status with a rapid HIV test (and possibly a confirmatory lab test if needed)
- Agree to stop cannabis for at least 1 week before and during the study (a saliva test may check THC)
- Not be pregnant
- Not have certain conditions that affect the brain, seizures, kidneys/lungs, or hepatitis C
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how depression and its treatment may affect the brain and immune-related body systems in people with HIV. You may be eligible if you have depression and a well-controlled HIV viral load, and you can safely complete brain MRI scans.
This Phase 2 study tests whether cannabidiol (CBD) and tetrahydrocannabinol (THC) change the gut microbiome and brain-related inflammation in people with HIV. It may help researchers understand new ways to reduce inflammation, but you would need strict cannabis and CBD/THC avoidance during the study.
This early (Phase 1) study tests how an oral THC and CBD product affects the body in healthy adults who use cannabis only rarely. It may help researchers understand safety and effects before larger studies.
This study looks at brain activity to understand how depression and cannabis use may be linked in young adults living with HIV. It mainly involves questionnaires, mental health screening, and brain scans, which may help researchers better understand risk factors and brain “underpinnings.”
This study looks at whether ongoing marijuana use changes “brain inflammation” and brain cell injury in people living with HIV. It may help researchers understand potential risks or protective effects and how treatment and brain health interact.
This study looks at how a cannabis extract affects brain activity in healthy young adults who use cannabis occasionally. It uses brain scans to understand changes and may help guide future treatments.
Hear when a new HIV-1-infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.